US 11,866,436 B2
Benzo[c][2,6]naphthyridine derivatives, compositions and therapeutic uses thereof
Marko Juhana Hyvonen, Cambridge (GB); Paul Brear, Cambridgeshire (GB); David Robert Spring, Cambridgeshire (GB); and Paul Glossop, Cambridgeshire (GB)
Assigned to Cambridge Enterprise Limited, Cambridge (GB)
Filed by Cambridge Enterprise Limited, Cambridge (GB)
Filed on Apr. 14, 2023, as Appl. No. 18/134,894.
Application 18/134,894 is a continuation of application No. PCT/GB2022/050536, filed on Feb. 28, 2022.
Claims priority of application No. 2102895 (GB), filed on Mar. 1, 2021.
Prior Publication US 2023/0250097 A1, Aug. 10, 2023
Int. Cl. C07D 471/04 (2006.01)
CPC C07D 471/04 (2013.01) 2 Claims
 
1. A compound of the formula:

OG Complex Work Unit Chemistry
(5-(2-(4-((3,5-difluoro-4-(trifluoromethoxy)benzyl)amino)butoxy)ethoxy)benzo[c][2,6]naphthyridine-8-carboxylic acid) or a pharmaceutically acceptable salt thereof.